News 20 Nov 2023 Roche investing an additional 1.2 billion Swiss francs in Basel Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment will be used to finance...
News 03 Nov 2023 A new gel offers targeted relief for ulcerative colitis patients Researchers at the University of Bern have developed a lipid gel for direct, localized treatment of ulcerative colitis, aiming to reduce side eff...
News 20 Dic 2023 Proteomedix and Blue Water Biotech jointly found Onconetix Proteomedix has been acquired by Blue Water Biotech, which is based in Cincinnati in the US State of Ohio. The two firms have now jointly founded...
News 01 Nov 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
News 13 Nov 2023 Bern’s journey to becoming a world-class medtech hub by 2030 The canton of Bern is on a mission to become a leading global medical hub by 2030. By combining an exceptional medical expertise medical expertis...
News 19 Dic 2023 Socorex wins CSEM’s prestigious Digital Journey Award 2023 Socorex, a leader in precision dosing instruments, has won the CSEM’s Digital Journey Award 2023, for its digital innovation in animal health.
Aktuell 03 Abr 2024 Nouscom erhält weitere Mittel für Krebsimpfstoffe Nouscom hat eine Investition in der Höhe von 7 Millionen Euro von der italienischen Risikokapitalfirma Angelini Ventures erhalten. Damit kann das...
News 16 Mayo 2023 NewBiologix pioneers breakthrough gene therapies with USD 50 million investment NewBiologix, a biotechnology start-up founded by industry veterans Igor Fisch and Nicolas Mermod, has announced a USD 50 million Series A funding...
Aktuell 13 Mar 2024 PSI entwickelt neue Krebstherapie Forschende des Paul Scherrer Instituts (PSI) haben ein Radiopharmakon gegen metastasierende neuroendokrine Tumore entwickelt. Mit der erstmaligen...
News 14 Dic 2020 Researchers use holography for surgery A team from Balgrist University Hospital has carried out the world’s first holographically navigated spinal operation with direct navigation. Thi...
News 20 Oct 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
News 10 Nov 2023 Researchers heal wounds with lactobacilli Researchers from Switzerland and the USA have jointly developed a dressing that uses probiotics to eliminate pathogens in chronic wounds. The pro...
Expertise 21 Ene 2019 «Les entreprises suisses méconnaissent les débouchés dans les sciences de la vie en Corée» Dans les sciences de la vie, les sociétés suisses ont le réflexe de se tourner vers la Chine ou le Japon. Pour Roger Zbinden, responsable d...
Global Opportunities 05 Jul 2018 La Corea estende la copertura sanitaria – opportunità per le aziende svizzere medtech Cambiamenti nella copertura assicurativa sanitaria nazionale coreana aumenteranno la domanda di tecnologia medicale avanzata. Essendo la Svizzera...
Aktuell 27 Mar 2024 TissueLabs startet Biofabrikation in Bellinzona TissueLabs sichert sich 800'000 Dollar und eröffnet ein neues Zentrum für Biofabrikation in Bellinzona. Die Mittel dienen der Verbesserung der ei...
Research and Development 11 Jul 2023 Benefit from R&D Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...
ニュース 09 Nov 2022 住友ファーマ子会社スミトバント社が、マイオバント社の全株式取得へ 住友ファーマ株式会社子会社のスミトバント社が、マイオバント社の株式100%を取得し、完全子会社化を進めていることを発表しました。現在のスミトバント社によるマイオバント社出資比率は52%で、同取引におけるマイオバント社の企業価値が29億米ドルとされています。
Member of the Month 09 Ene 2023 Lyfegen HealthTech AG: “Working together with S-GE gives us credibility and trust” While new and groundbreaking treatments like cell and gene therapies are saving lives, the price of treatment can be substantial, costing million...